Line 21: | Line 21: | ||
} | } | ||
− | .foto-grande div { | + | .foto-grande div {display: inline-block} |
@font-face { | @font-face { |
Revision as of 13:39, 1 November 2017
iGEM AQA_Unesp
INSUBIOTA
treating diabetes with genetically engineered probiotic
Line 21: | Line 21: | ||
} | } | ||
− | .foto-grande div { | + | .foto-grande div {display: inline-block} |
@font-face { | @font-face { |